UNSPSC 51382901: Glucosamine

This classification denotes a nutritional supplement with the molecular formula C6H13NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N08U5BOQ1K, chemically known as mannopyranose, 2-amoino-2-deoxy-, d- (8ci) but generally known as glucosamine, which bears US NIH Compound Identifier 739. European Medicines Agency schedules Glucosamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07937MIG.

UNSPSC 51382901 Glucosamine is a Commodity code that does not reflect the pharmaceutical procurement activity currently tagged under it in state and local government contracting. The three recent opportunities posted under this code involve naloxone and drug deactivation systems, a pharmacy benefit initiative, and generic multi-source pharmaceuticals and OTC products—none of which are glucosamine or joint-health supplements. The code shows a tagging mismatch between its nominal scope and actual state and local buying patterns; issuing bodies include counties (Seminole County, Florida), state health and human services departments (Texas HHS Commission), and state-level cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance). Recent work centers on emergency-response pharmaceuticals, direct-to-manufacturer prescription programs, and broad pharmaceutical supply agreements rather than dietary supplements or joint-care products.

The geographic spread spans Florida, Texas, and Minnesota, with activity driven by county health departments, state HHS commissions, and multi-state cooperative purchasing vehicles. Representative recent opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for procurement of 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026) on direct-to-manufacturer prescription capability; and the Minnesota Department of Administration's RFP S1070000015802 through MMCAP (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products to be supplied through authorized wholesalers with an effective date of July 1, 2026. The code shows little relevant recent activity aligned with its stated glucosamine classification, suggesting either a classification error in source data or a shift in the code's actual use that does not match its name.